Evidence map›Paper›PMID 42201289›Full record

ArticleJournal of the American College of Cardiology2026

Implications of Modest Reductions in ABI Measurements for Risk of Major Adverse Limb Events Among 223,350 Veterans.

Aaron W Aday, Svetlana K Eden, Suman Kundu, Robert A Greevy, Amy Anderson-Mellies, Patrick R Alba, Charles W Alcorn, Alexander E Sullivan, Hilary A Tindle, Joshua A Beckman and 1 more

Abstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aaron W AdayVanderbilt Translational and Clinical Cardiovascular Research Center, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: aaron.w.aday@vumc.org.
Svetlana K EdenDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Suman KunduVanderbilt Translational and Clinical Cardiovascular Research Center, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Robert A GreevyDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Health Services Research, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Amy Anderson-MelliesVanderbilt Translational and Clinical Cardiovascular Research Center, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Patrick R AlbaVA Salt Lake City Health Care System, Salt Lake City, Utah, USA; Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Charles W AlcornUniversity of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA.
Alexander E SullivanVanderbilt Translational and Clinical Cardiovascular Research Center, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Hilary A TindleDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Geriatric Research Education and Clinical Centers, Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee, USA.
Joshua A BeckmanDivision of Vascular Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Matthew S FreibergVanderbilt Translational and Clinical Cardiovascular Research Center, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Geriatric Research Education and Clinical Centers, Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee, USA.

Funding

The HIV and Alcohol Research center focused on Polypharmacy (HARP)P01AA029545 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2021 to 2025
$6.3M
Sex Disparities in Overall Response to ART Among HIV Infected IndividualsU24AA020794 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2011 to 2020
$5.5M
The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery DiseaseK23HL151871 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ADAY, AARON W. · 2021 to 2025
$927k
NHLBI NIH HHS K23 HL151871NIAAA NIH HHS P01 AA029545NIAAA NIH HHS U24 AA020794
6 · The paper itself

Abstract

backgroundLow resting ankle-brachial index (ABI) is a marker of poor cardiovascular outcomes. Whether modest decrements in ABI translate into higher risks of major adverse limb events (MALE) is unclear because prior studies are small or lack racial diversity and incident outcomes.

objectivesThe purpose of this study was to assess the association between the full range of ABI measures and incident MALE in a large, diverse cohort.

methodsUsing data from the Veterans Aging Cohort Study-National Cohort, we analyzed a prospective, longitudinal cohort of veterans free of prevalent peripheral artery disease (PAD). Participants were enrolled beginning January 1, 2000, and followed through September 30, 2021. The exposure was resting ABI (continuous and categorical), and the primary outcome was MALE, defined as amputation or revascularization using administrative codes. Secondary outcomes included total amputation, major amputation, or revascularization. Cox proportional hazards models assessed the overall association between ABI and MALE and stratified by sex or race. Models were adjusted for demographics and PAD risk factors.

resultsThe analysis included 223,350 people, including 8,207 women and 42,173 Black individuals. There were 28,191 MALE. Risk of MALE followed an inverse j-shaped distribution across the continuous ABI spectrum. Compared with a categorical ABI of 1.11 to 1.20, borderline ABI values (range 0.91-1.00) were associated with an increased risk of MALE in the total population as well as sex/race subgroups: total population: HR: 1.53 (95% CI: 1.43-1.64); men: HR: 1.53 (95% CI: 1.43-1.64); women: HR: 2.00 (95% CI: 1.18-3.38); White individuals: HR: 1.60 (95% CI: 1.48-1.73); Black individuals: HR: 1.39 (95% CI: 1.18-1.64). Similar associations were demonstrated for major amputation (HR: 1.34 [95% CI: 1.17-1.54]), total amputation (HR: 1.22 [95% CI: 1.12-1.33]), and revascularization (HR: 2.05 [95% CI: 1.87-2.26]) in the full cohort. ABI was a stronger marker of MALE risk than established risk factors, including current smoking and prevalent cardiovascular disease.

conclusionsIn a large, diverse cohort free of prior PAD, ABI values across the full spectrum were associated with an increased risk of incident MALE, suggesting that treating the ABI as a binary measure does not adequately capture clinical risk. Further studies are needed to better understand why MALE occurs despite near-normal ABI values.

Indexed as

Amputation, SurgicalAnkle Brachial IndexPeripheral Arterial DiseaseVeteransAgedHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesRisk FactorsUnited Statesamputationankle-brachial indexperipheral artery diseaserevascularization

Identifiers

PMID42201289
PMCPMC13355317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.